There’s a cure for hepatitis C now; next up is figuring out how to pay for it.
For a long time, conspiracy theorists posited that the pharmaceutical industry wouldn’t create drugs to actually cure disease, because it wasn’t profitable to help patients get and stay better. There was more money to be made, this cynical narrative went, in developing medicines that must be taken every day forever. Those who’ve dedicated their lives to searching for cures understandably found this accusation offensive.
Yet, here we are at the dawn of a new era of personalized medicine and miracle remedies. Our scientists have cured hepatitis C, but many payers don’t want to pay despite the opportunity to solve a huge public health challenge and eradicate the leading cause of liver cancer and liver transplants in the United States.
A series of breakthrough cures for hepatitis C began earning approval from the U.S. Food & Drug Administration in 2014. More than 90 percent of patients who take these new medications are completely cured. They don’t go into remission; the underlying virus causing the disease is eradicated from their bodies in as little as eight weeks.
Read full article: Hepatitis C has a cure — now insurers just need to pay for it | TheHill
|Read Full Article: Hepatitis C has a cure — now insurers just need to pay for it | TheHill|